Video 16 Jan 2026 Orthocell Finalises Formal Agreement with Marine Biomedical and Secures Strategic Rights to Groundbreaking Bone Regeneration Technology, PearlBoneâ„¢ Orthocell has entered into a binding Formal Agreement with @Marine Biomedical, increasing its equity interest from 1.72% to 11.7% for a total… Orthocell
Company News 06 Jan 2026 Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m For the quarter ended 31 December 2025, the Company achieved record quarterly revenue of $3.2 million, representing a 7.0% increase on the… Orthocell
Company News 15 Dec 2025 Orthocell Submits Regulatory Application for Remplirâ„¢ into EU and UK Orthocell has submitted a regulatory application to the British Standards Institution (BSI) seeking approval to commercially distribute Remplirâ„¢ in the… Orthocell
Company News 10 Dec 2025 Orthocell Strengthens Asian Growth Platform with First Commercial Sales in Hong Kong Orthocell has announced that it has completed the first commercial sales of Remplirâ„¢ in Hong Kong, representing a key milestone… Orthocell
Company News 20 Nov 2025 Remplir™ Nerve Sparing Prostate Cancer Surgery Commercial Opportunity Gathers Momentum Momentum is growing for Remplir™ in nerve-sparing prostate cancer surgery, with around 100 surgeries now performed using the flagship nerve repair device. Orthocell
Company News 05 Nov 2025 Orthocell Appoints Second Canadian Distributor for Remplirâ„¢ Orthocell has appointed its second distributor in Canada. The appointment completes national coverage across the US$75 million Canadian market, ensuring… Orthocell
Company News 03 Nov 2025 First Remplirâ„¢ Surgical Case Completed in Hong Kong Orthocell has announced the successful completion of the first Remplirâ„¢ surgical case in Hong Kong and the official launch of… Orthocell
Company News 30 Oct 2025 Professor Minghao Zheng elected Fellow of the Australian Academy of Health and Medical Sciences  Professor Minghao Zheng, Orthocell’s Co-Founder and Chief Scientific Officer, has been elected as a Fellow of the Australian Academy of… Orthocell
Company News 29 Oct 2025 Orthocell Appoints Exclusive Remplirâ„¢ Distributor for Hong Kong Orthocell has appointed medical device distributor MontsMed as its exclusive in-country distributor for Remplir in the key Asian market of… Orthocell
Company News 20 Oct 2025 Orthocell secures global distribution rights to innovative bone regeneration technology Orthocell has signed Memorandum of Understanding to increase its equity stake in Marine Biomedical - from 1.7% to 12.0% for… Orthocell
